Literature DB >> 30205144

Surgery for Tumors of the Heart.

Bobby Yanagawa1, Amine Mazine2, Edward Y Chan3, Colin M Barker4, Michael Gritti2, Ross M Reul5, Vinod Ravi6, Sergio Ibarra5, Oz M Shapira7, Robert J Cusimano2, Michael J Reardon8.   

Abstract

Most surgeons will encounter only a handful of primary cardiac tumors outside of myxomas. Approximately 3 quarters of primary cardiac tumors are benign and 1 quarter is malignant. In most cases, cardiac tumors are silent but when symptoms do occur, they are primarily determined by tumor size and anatomical location, not by histopathology. The diagnosis and preoperative imaging relies heavily on multimodal imaging including echocardiography, computed tomography, magnetic resonance imaging, and coronary angiography. Surgical resection is the most common treatment for most simple primary cardiac tumors and for some complex benign tumors. Surgical resection of primary cardiac tumors frequently involves the need for complex cardiac reconstruction, particularly when malignant. Secondary tumors to the heart are 30 times more frequent than primary cardiac tumors, and their incidence is increasing, largely as a result of advances in cancer diagnosis and therapy. Surgical resection is feasible in only a small fraction of highly-selected patients with secondary tumors to the heart. For complex benign tumors-such as paraganglioma or large fibromas-and all primary and secondary malignant tumors, a multidisciplinary cardiac tumor team review in experienced centers of excellence is recommended.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  cardiac tumor; malignant tumor; sarcoma; tumor team

Mesh:

Year:  2018        PMID: 30205144     DOI: 10.1053/j.semtcvs.2018.09.001

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  8 in total

1.  Benign Cardiac Neoplasms in the United States: A Thirteen-Year Review.

Authors:  Neiberg de Alcantara Lima; Kristina Byers-Spencer; Kamil Cwikla; Cuyler Huffman; Mireya Diaz; Thomas A Melgar; Nicholas Helmstetter
Journal:  Cardiology       Date:  2021-09-01       Impact factor: 1.869

2.  Fibroelastoma papilar valvular aórtico: causa atípica de ictus.

Authors:  Carlos Domínguez-Massa; Tomás Heredia-Cambra; José A Rincón-Almanza; María J Dalmau-Sorlí; Francisco J Valera-Martínez; Juan B Martínez-León
Journal:  Arch Cardiol Mex       Date:  2021-11-01

3.  Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy.

Authors:  Polona Gams; Zvezdana Dolenc Stražar; Maja Šoštarič; Matic Bošnjak; Juš Kšela
Journal:  Case Rep Oncol       Date:  2021-03-29

4.  Surgical treatment of primary cardiac tumors: 20-year single center experience.

Authors:  Martin Děrgel; Ján Gofus; Petr Smolák; Václav Stejskal; Ivo Hanke; Jan Matějka; Jiří Manďák; Jan Vojáček
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-03-24

5.  Commentary: Trim the fat.

Authors:  Thomas E MacGillivray; Michael J Reardon
Journal:  JTCVS Tech       Date:  2021-11-11

6.  Outcomes of Octogenarians with Primary Malignant Cardiac Tumors: National Cancer Database Analysis.

Authors:  Mohamed Rahouma; Massimo Baudo; Anas Dabsha; Arnaldo Dimagli; Abdelrahman Mohamed; Stephanie L Mick; Leonard Girardi; Mario Gaudino; Roberto Lorusso
Journal:  J Clin Med       Date:  2022-08-20       Impact factor: 4.964

7.  Long-term follow-up of resection of primary benign right ventricular tumours: a 10-year surgical experience.

Authors:  E Qiao; Y Wang; Z Huang; F Li; W Wang
Journal:  Ann R Coll Surg Engl       Date:  2020-09-24       Impact factor: 1.891

8.  Endovascular brachytherapy for extensive right-heart and pulmonary artery sarcoma - a case report.

Authors:  Gal Aviel; Amichay Meirovitz; David Planer; Dotan Cohen; Dan Gilon; Jon Feldman; Oz M Shapira
Journal:  J Contemp Brachytherapy       Date:  2019-12-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.